Home > Publications database > Gallstones, Body Mass Index, C-reactive Protein and Gallbladder Cancer - Mendelian Randomization Analysis of Chilean and European Genotype Data. > print |
001 | 163033 | ||
005 | 20240229133508.0 | ||
024 | 7 | _ | |a pmid:32893372 |2 pmid |
024 | 7 | _ | |a 0270-9139 |2 ISSN |
024 | 7 | _ | |a 1527-3350 |2 ISSN |
024 | 7 | _ | |a doi: 10.1002/hep.31537. |2 doi |
037 | _ | _ | |a DKFZ-2020-01824 |
041 | _ | _ | |a eng |
082 | _ | _ | |a 610 |
100 | 1 | _ | |a Barahona Ponce, Carol |b 0 |
245 | _ | _ | |a Gallstones, Body Mass Index, C-reactive Protein and Gallbladder Cancer - Mendelian Randomization Analysis of Chilean and European Genotype Data. |
260 | _ | _ | |a New York [u.a.] |c 2021 |b Wiley Interscience |
336 | 7 | _ | |a article |2 DRIVER |
336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1620734294_5121 |2 PUB:(DE-HGF) |
336 | 7 | _ | |a ARTICLE |2 BibTeX |
336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
500 | _ | _ | |a 2021 May;73(5):1783-1796 |
520 | _ | _ | |a Gallbladder cancer (GBC) is a neglected disease with substantial geographical variability: Chile shows the highest incidence worldwide, while GBC is relatively rare in Europe. Here we investigate the causal effects of risk factors considered in current GBC prevention programmes as well as C-reactive protein (CRP) level as a marker of chronic inflammation.We applied two-sample Mendelian randomization (MR) using publicly available data and our own data from a retrospective Chilean and a prospective European study. Causality was assessed by inverse variance weighted (IVW), MR-Egger regression and weighted median estimates complemented with sensitivity analyses on potential heterogeneity and pleiotropy, two-step MR and mediation analysis. We found evidence for a causal effect of gallstone disease on GBC risk in Chileans (p = 9 × 10-5 ) and Europeans (p = 9 × 10-5 ). A genetically elevated body mass index (BMI) increased GBC risk in Chileans (p = 0.03), while higher CRP concentrations increased GBC risk in Europeans (p = 4.1 × 10-6 ). European results suggest causal effects of BMI on gallstone disease (p = 0.008); public Chilean data were not, however, available to enable assessment of the mediation effects among causal GBC risk factors.Two risk factors considered in the current Chilean programme for GBC prevention are causally linked to GBC risk: gallstones and BMI. For Europeans, BMI showed a causal effect on gallstone risk, which was itself causally linked to GBC risk. |
536 | _ | _ | |a 313 - Krebsrisikofaktoren und Prävention (POF4-313) |0 G:(DE-HGF)POF4-313 |c POF4-313 |x 0 |f POF IV |
588 | _ | _ | |a Dataset connected to PubMed, |
700 | 1 | _ | |a Scherer, Dominique |b 1 |
700 | 1 | _ | |a Brinster, Regina |b 2 |
700 | 1 | _ | |a Boekstegers, Felix |0 0000-0002-0587-7624 |b 3 |
700 | 1 | _ | |a Marcelain, Katherine |b 4 |
700 | 1 | _ | |a Gárate, Valentina |b 5 |
700 | 1 | _ | |a Müller, Bettina |b 6 |
700 | 1 | _ | |a de Toro, Gonzalo |b 7 |
700 | 1 | _ | |a Retamales, Javier |b 8 |
700 | 1 | _ | |a Barajas, Olga |b 9 |
700 | 1 | _ | |a Ahumada, Monica |b 10 |
700 | 1 | _ | |a Morales, Erik |b 11 |
700 | 1 | _ | |a Rojas, Armando |b 12 |
700 | 1 | _ | |a Sanhueza, Verónica |b 13 |
700 | 1 | _ | |a Loader, Denisse |b 14 |
700 | 1 | _ | |a Rivera, María Teresa |b 15 |
700 | 1 | _ | |a Gutiérrez, Lorena |b 16 |
700 | 1 | _ | |a Bernal, Giuliano |b 17 |
700 | 1 | _ | |a Ortega, Alejandro |b 18 |
700 | 1 | _ | |a Montalvo, Domingo |b 19 |
700 | 1 | _ | |a Portiño, Sergio |b 20 |
700 | 1 | _ | |a Bertrán, Maria Enriqueta |b 21 |
700 | 1 | _ | |a Gabler, Fernando |b 22 |
700 | 1 | _ | |a Spencer, Loreto |b 23 |
700 | 1 | _ | |a Olloquequi, Jordi |b 24 |
700 | 1 | _ | |a Fischer, Christine |b 25 |
700 | 1 | _ | |a Jenab, Mazda |b 26 |
700 | 1 | _ | |a Aleksandrova, Krasimira |b 27 |
700 | 1 | _ | |a Katzke, Verena |0 P:(DE-He78)fb68a9386399d72d84f7f34cfc6048b4 |b 28 |u dkfz |
700 | 1 | _ | |a Weiderpass, Elisabete |0 0000-0003-2237-0128 |b 29 |
700 | 1 | _ | |a Bonet, Catalina |b 30 |
700 | 1 | _ | |a Moradi, Tahereh |b 31 |
700 | 1 | _ | |a Fischer, Krista |b 32 |
700 | 1 | _ | |a Bossers, Willem |b 33 |
700 | 1 | _ | |a Brenner, Hermann |0 P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2 |b 34 |u dkfz |
700 | 1 | _ | |a Hveem, Kristian |b 35 |
700 | 1 | _ | |a Eklund, Niina |b 36 |
700 | 1 | _ | |a Völker, Uwe |b 37 |
700 | 1 | _ | |a Waldenberger, Melanie |b 38 |
700 | 1 | _ | |a Fuentes Guajardo, Macarena |b 39 |
700 | 1 | _ | |a Gonzalez-Jose, Rolando |b 40 |
700 | 1 | _ | |a Bedoya, Gabriel |b 41 |
700 | 1 | _ | |a Bortolini, Maria C |b 42 |
700 | 1 | _ | |a Canizales, Samuel |b 43 |
700 | 1 | _ | |a Gallo, Carla |b 44 |
700 | 1 | _ | |a Ruiz Linares, Andres |b 45 |
700 | 1 | _ | |a Rothhammer, Francisco |b 46 |
700 | 1 | _ | |a Lorenzo Bermejo, Justo |b 47 |
773 | _ | _ | |a 10.1002/hep.31537. |0 PERI:(DE-600)1472120-x |n 5 |p 1783-1796 |t Hepatology |v 73 |y 2021 |x 0270-9139 |
909 | C | O | |o oai:inrepo02.dkfz.de:163033 |p VDB |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 28 |6 P:(DE-He78)fb68a9386399d72d84f7f34cfc6048b4 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 34 |6 P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2 |
913 | 0 | _ | |a DE-HGF |b Gesundheit |l Krebsforschung |1 G:(DE-HGF)POF3-310 |0 G:(DE-HGF)POF3-313 |3 G:(DE-HGF)POF3 |2 G:(DE-HGF)POF3-300 |4 G:(DE-HGF)POF |v Cancer risk factors and prevention |x 0 |
913 | 1 | _ | |a DE-HGF |b Gesundheit |l Krebsforschung |1 G:(DE-HGF)POF4-310 |0 G:(DE-HGF)POF4-313 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Krebsrisikofaktoren und Prävention |x 0 |
914 | 1 | _ | |y 2021 |
915 | _ | _ | |a Nationallizenz |0 StatID:(DE-HGF)0420 |2 StatID |d 2020-02-26 |w ger |
915 | _ | _ | |a DEAL Wiley |0 StatID:(DE-HGF)3001 |2 StatID |d 2020-02-26 |w ger |
915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b HEPATOLOGY : 2018 |d 2020-02-26 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2020-02-26 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2020-02-26 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0310 |2 StatID |b NCBI Molecular Biology Database |d 2020-02-26 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2020-02-26 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1110 |2 StatID |b Current Contents - Clinical Medicine |d 2020-02-26 |
915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0110 |2 StatID |b Science Citation Index |d 2020-02-26 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2020-02-26 |
915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0111 |2 StatID |b Science Citation Index Expanded |d 2020-02-26 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2020-02-26 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1190 |2 StatID |b Biological Abstracts |d 2020-02-26 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |d 2020-02-26 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |d 2020-02-26 |
915 | _ | _ | |a IF >= 10 |0 StatID:(DE-HGF)9910 |2 StatID |b HEPATOLOGY : 2018 |d 2020-02-26 |
920 | 1 | _ | |0 I:(DE-He78)C020-20160331 |k C020 |l C020 Epidemiologie von Krebs |x 0 |
920 | 1 | _ | |0 I:(DE-He78)C070-20160331 |k C070 |l C070 Klinische Epidemiologie und Alternf. |x 1 |
920 | 1 | _ | |0 I:(DE-He78)C120-20160331 |k C120 |l Präventive Onkologie |x 2 |
920 | 1 | _ | |0 I:(DE-He78)HD01-20160331 |k HD01 |l DKTK HD zentral |x 3 |
980 | _ | _ | |a journal |
980 | _ | _ | |a VDB |
980 | _ | _ | |a I:(DE-He78)C020-20160331 |
980 | _ | _ | |a I:(DE-He78)C070-20160331 |
980 | _ | _ | |a I:(DE-He78)C120-20160331 |
980 | _ | _ | |a I:(DE-He78)HD01-20160331 |
980 | _ | _ | |a UNRESTRICTED |
Library | Collection | CLSMajor | CLSMinor | Language | Author |
---|